Author

Vinicius Kannen

University of TorontoORCID 0000-0001-6290-8063Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Organism:human· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Hani Choksi· 2 shared Jason B. MatthewsiD· 2 shared Landon J. EdgariD· 2 shared Paolo GiulianaiD· 2 shared Aled Blundell· 1 shared Antanas GulbinasiD· 1 shared David B. Avila· 1 shared David G. BrooksiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Hani Choksi

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyCell ReportsPeer-reviewedJul 1, 2025

A Unified Atlas of T cell Glycophysiology

Fauzia N. Izzati, Hani Choksi, Paolo Giuliana…·Landon J. Edgar

This study characterizes T cell glycosylation patterns across mouse and human tissues, revealing species-specific differences in glycan profiles and dynamics.

17 citationstop 4%

mousehuman

𝕏 PostBluesky

Cancer BiologyFrontiers in ImmunologyPeer-reviewedJan 10, 2025

Loss of PARP7 increases type I interferon signalling and prevents pancreatic tumour growth by enhancing immune cell infiltration

Vinicius Kannen, Marit Rasmussen, Siddhartha Das…·Jason B. Matthews

This study shows that loss of PARP7 in pancreatic cancer cells increases type I interferon signaling and enhances immune cell infiltration, leading to reduced tumor growth.

5 citations

mousebulk RNA-seq

𝕏 PostBluesky